Randomized comparison of intravenous versus intracoronary streptokinase for myocardial infarction.

The efficacy of intravenous (i.v.) thrombolytic therapy has not been firmly established in comparison with the intracoronary (i.

Fate of therapy failures in adult idiopathic thrombocytopenic purpura.

Of 38 adult patients with idiopathic thrombocytopenic purpura followed an average of more than 12 years, 15 suffered splenectomy failure or postsplenectomy recurrence of thrombocytopenia. Nine of the 15 also received immunosuppressive agents, and four of the nine failed such therapy. In eight of these 15 treatment failures normal or safe platelet counts were achieved in a subsequent three to 12 year period during which they received no therapy.

Successful streptokinase therapy for catheter-induced subclavian vein thrombosis.

Synotinatuc subclavian vein thrombosis developed in a patient receiving long-term parenteral nutrition. Serial phlebograms showed progression of venous thrombosis, despite therapy with heparin. Fibrinolytic therapy with streptoikinase, monitored in the laboratory by the euglobulin clot lysis time, was strikingly successful and may be the treatment of choice for this condition if certain contraindications are absent.

Subacute myeloid leukemia: a clinical review.

The data on 31 patients who fit into the clinical spectrum of subacute myeloid leukemia have been reviewed. The majority of patients were male with a median age of 61 years. The interval from onset of symptoms to actual diagnosis was extremely variable, with a mean of 16 months and a median of six months.